PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Detail   |   Print    Next page > 
     
SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
2026-10-08T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Helfie Signs MOU with Homa Bay Kenya Ministry of Health for TB and Hypertension Screening Pilot
2026-10-08T    Computer/Electronics   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
MAYBELLINE NEW YORK LAUNCHES "TOGETHER WE'RE BRAVE" CAMPAIGN FOR WORLD MENTAL HEALTH DAY
2026-10-08T    Cosmetics & Personal Care   Health Care/Hospital   Household/Consumer/Cosmetics   Medical/Pharmaceuticals 
Nuevocor Doses First Patient in SUNBEAM-LMNA Phase 1/2 Trial and Receives FDA Fast Track Designation for NVC-001 in LMNA Dilated Cardiomyopathy
2026-10-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
LOTTE Biologics and Alvotech announce US-based manufacturing agreement to increase global supply
2026-10-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Löviselle LEAP Advances Across Singapore and Malaysia: Building a Regional Platform for Bio-Active Regeneration
2026-10-08T    Biotechnology   Cosmetics & Personal Care   Health Care/Hospital   Medical/Pharmaceuticals 
Ribo Submits European Clinical Trial Application for Phase Ⅰ Study of INHBE-Targeting siRNA RBD3133
2026-10-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
NCCN Highlights Collaborations to Improve Global Cancer Outcomes During Meetings in North America and Asia
2026-10-08T    Health Care/Hospital   Medical/Pharmaceuticals   Travel 
WuXi AppTec Earns EcoVadis Gold Medal for Third Consecutive Year, Ranking Among Global Top 5% for Sustainability
2026-10-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Asieris Pharmaceuticals Enters an Exclusive Licensing Agreement with Theramex for CEVIRA® subject to certain conditions, Advancing the Global Development and Commercialization of a Non-Surgical Treatment for Cervical Precancerous Lesions in Europe
2026-10-07T    Biotechnology   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.